Incretin manipulation in diabetes management

doi:10.4239/wjd.v6.i6.774

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9475)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

489

WORD

335

HTML

4007

Figures (1-1)

264

Tables (1-2)

208

Sum=5303

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

653

Download

1401

Sum=2054

Publishing Process of This Article

Item

Count

Browse

933

Download

1185

Sum=2118

Jun 25, 2015 (publication date) through Nov 12, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Diabetes. Jun 25, 2015; 6(6): 774-781
Published online Jun 25, 2015. doi: 10.4239/wjd.v6.i6.774

Full Size Figure Download Figure

Figure 1 Physiological aspects of incretin hormones in the body. GLP-1: Glucagon-like peptide-1; GIP: Glucose-dependent insulinotropic polypeptide.

Citation: Pappachan JM, Raveendran A, Sriraman R. Incretin manipulation in diabetes management. World J Diabetes 2015; 6(6): 774-781
URL: https://www.wjgnet.com/1948-9358/full/v6/i6/774.htm
DOI: https://dx.doi.org/10.4239/wjd.v6.i6.774